002412 汉森制药
已收盘 07-25 15:00:00
资讯
新帖
简况
汉森制药(002412)5月30日股东户数2.48万户，较上期减少2.44%
证券之星 · 06-24
汉森制药(002412)5月30日股东户数2.48万户，较上期减少2.44%
汉森制药收盘上涨1.70%，滚动市盈率17.40倍，总市值30.14亿元
金融界 · 06-23
汉森制药收盘上涨1.70%，滚动市盈率17.40倍，总市值30.14亿元
汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》
证券之星 · 06-20
汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》
每周股票复盘：汉森制药（002412）股东户数减少620户，户均持股增加
证券之星 · 06-14
每周股票复盘：汉森制药（002412）股东户数减少620户，户均持股增加
汉森制药：公司在产品研发方面，中药新药苁蓉颗粒正在进行临床前研究
证星董秘互动 · 06-12
汉森制药：公司在产品研发方面，中药新药苁蓉颗粒正在进行临床前研究
汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人
证券之星 · 06-11
汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人
每周股票复盘：股本股东变化，汉森制药（002412）股东户数减少620户
证券之星 · 06-07
每周股票复盘：股本股东变化，汉森制药（002412）股东户数减少620户
汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人
证券之星 · 06-04
汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人
每周股票复盘：汉森制药（002412）股东户数增加294户，户均持股减少
证券之星 · 05-24
每周股票复盘：汉森制药（002412）股东户数增加294户，户均持股减少
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
证券之星 · 05-23
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
汉森制药：公司经营状况正常，无应披露未披露重大事项
金融界 · 05-16
汉森制药：公司经营状况正常，无应披露未披露重大事项
汉森制药：公司目前经营状况正常且未有应披露而未披露的重大事项
证券之星 · 05-16
汉森制药：公司目前经营状况正常且未有应披露而未披露的重大事项
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
证券之星 · 05-14
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
汉森制药：截至2025年4月30日公司含信用账户合并股东名册的股东总数为25406人
证券之星 · 05-14
汉森制药：截至2025年4月30日公司含信用账户合并股东名册的股东总数为25406人
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
证券之星 · 05-08
汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%
汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》
证券之星 · 04-30
汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》
异动快报：汉森制药（002412）4月28日9点38分触及跌停板
证券之星 · 04-28
异动快报：汉森制药（002412）4月28日9点38分触及跌停板
汉森制药（002412）2025年一季报简析：增收不增利
证券之星 · 04-26
汉森制药（002412）2025年一季报简析：增收不增利
图解汉森制药一季报：第一季度单季净利润同比减80.68%
证券之星 · 04-25
图解汉森制药一季报：第一季度单季净利润同比减80.68%
汉森制药(002412.SZ)发布一季度业绩，归母净利润1125.72万元，同比下降80.68%
智通财经 · 04-25
汉森制药(002412.SZ)发布一季度业绩，归母净利润1125.72万元，同比下降80.68%
加载更多
公司概况
公司名称：
湖南汉森制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-25
主营业务：
湖南汉森制药股份有限公司的主营业务是传统中成药制剂、化学药、医用制剂的研发、生产和销售。公司的主要产品是中成药、化学药、医用制剂。
发行价格：
35.80
{"stockData":{"symbol":"002412","market":"SZ","secType":"STK","nameCN":"汉森制药","latestPrice":6.74,"timestamp":1753427016000,"preClose":6.76,"halted":0,"volume":8775900,"delay":0,"changeRate":-0.003,"floatShares":498000000,"shares":503000000,"eps":0.3443,"marketStatus":"已收盘","change":-0.02,"latestTime":"07-25 15:00:00","open":6.79,"high":6.87,"low":6.7,"amount":59654300,"amplitude":0.0251,"askPrice":6.75,"askSize":1431,"bidPrice":6.74,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.3443,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.76,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":7.44,"lowLimit":6.08,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":503200000,"isCdr":false,"pbRate":1.55,"roa":"--","peRate":19.575951,"roe":"0.51%","epsLYR":0.4377,"committee":-0.504889,"marketValue":3392000000,"turnoverRate":0.0176,"status":1,"floatMarketCap":3355000000},"requestUrl":"/m/hq/s/002412","defaultTab":"news","newsList":[{"id":"2545140207","title":"汉森制药(002412)5月30日股东户数2.48万户，较上期减少2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545140207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545140207?lang=zh_cn&edition=full","pubTime":"2025-06-24 17:19","pubTimestamp":1750756775,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2025年5月30日公司股东户数为2.48万户，较4月30日减少620.0户，减幅为2.44%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至5月30日，中药行业平均股东户数为5.31万户。从股价来看，2025年4月30日至2025年5月30日，汉森制药区间涨幅为8.83%，在此期间股东户数减少620.0户，减幅为2.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400028117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0239","002412","BK0028"],"gpt_icon":0},{"id":"2545499851","title":"汉森制药收盘上涨1.70%，滚动市盈率17.40倍，总市值30.14亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545499851","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545499851?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:41","pubTimestamp":1750668077,"startTime":"0","endTime":"0","summary":"6月23日，汉森制药今日收盘5.99元，上涨1.70%，滚动市盈率PE达到17.40倍，总市值30.14亿元。从行业市盈率排名来看，公司所处的中药行业市盈率平均37.71倍，行业中值27.96倍，汉森制药排名第28位。截至2025年一季报，共有4家机构持仓汉森制药，其中其他2家、QFII1家、基金1家，合计持股数23833.55万股，持股市值14.54亿元。湖南汉森制药股份有限公司的主营业务是传统中成药制剂、化学药、医用制剂的研发、生产和销售。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/23164151240230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0039","BK0028","002412"],"gpt_icon":0},{"id":"2544976351","title":"汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》","url":"https://stock-news.laohu8.com/highlight/detail?id=2544976351","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544976351?lang=zh_cn&edition=full","pubTime":"2025-06-20 08:33","pubTimestamp":1750379590,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)06月19日在投资者关系平台上答复投资者关心的问题。投资者提问：很多公司都能做到每年分红，为什么贵公司都不能做到每年分红呢？汉森制药回复：尊敬的投资者您好，公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》，我们将严格执行现金分红规定和承诺，继续努力，为股东创造更多价值。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000004468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0239","BK0039"],"gpt_icon":0},{"id":"2543651938","title":"每周股票复盘：汉森制药（002412）股东户数减少620户，户均持股增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651938?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:32","pubTimestamp":1749864732,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，汉森制药报收于6.34元，较上周的6.19元上涨2.42%。本周，汉森制药6月10日盘中最高价报6.66元。汉森制药当前最新总市值31.9亿元，在中药板块市值排名52/68，在两市A股市值排名4059/5150。本周关注点股本股东变化：截至2025年5月30日公司股东户数为2.48万户，较4月30日减少620.0户股本股东变化近日汉森制药披露，截至2025年5月30日公司股东户数为2.48万户，较4月30日减少620.0户，减幅为2.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400010886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002412","BK0039","BK0028"],"gpt_icon":0},{"id":"2542551694","title":"汉森制药：公司在产品研发方面，中药新药苁蓉颗粒正在进行临床前研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2542551694","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542551694?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:01","pubTimestamp":1749690082,"startTime":"0","endTime":"0","summary":"投资者：湖南汉森制药股份有限公司发布公告称，其化学药品恩格列净片正式获得国家药监局签发的《药品注册证书》，适应症覆盖2型糖尿病及症状性慢性心力衰竭成人患者，这一消息在资本市场引发关注。请问目前这款药已经上市了没，谢谢汉森制药董秘：尊敬的投资者您好，恩格列净片10mg已经获得生产批文，可上市销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612090621977bc614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612090621977bc614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561510","562390","BK0028","BK0039","002412","BK0239"],"gpt_icon":0},{"id":"2542290783","title":"汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人","url":"https://stock-news.laohu8.com/highlight/detail?id=2542290783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542290783?lang=zh_cn&edition=full","pubTime":"2025-06-11 08:46","pubTimestamp":1749602775,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，请问公司到六月十日的股东人数，谢谢汉森制药回复：投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2025年5月30日，公司含信用账户合并股东名册的股东总数为:24786人。感谢您对公司的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100004368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0239","002412"],"gpt_icon":0},{"id":"2541818669","title":"每周股票复盘：股本股东变化，汉森制药（002412）股东户数减少620户","url":"https://stock-news.laohu8.com/highlight/detail?id=2541818669","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541818669?lang=zh_cn&edition=full","pubTime":"2025-06-07 12:28","pubTimestamp":1749270492,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘，汉森制药报收于6.19元，较上周的6.04元上涨2.48%。本周，汉森制药6月3日盘中最高价报6.46元。汉森制药当前最新总市值31.15亿元，在中药板块市值排名54/68，在两市A股市值排名4123/5148。本周关注点股本股东变化：截至2025年5月30日公司股东户数为2.48万户，较4月30日减少620.0户股本股东变化近日汉森制药披露，截至2025年5月30日公司股东户数为2.48万户，较4月30日减少620.0户，减幅为2.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0239","002412"],"gpt_icon":0},{"id":"2540758031","title":"汉森制药：截至2025年5月30日公司含信用账户合并股东名册的股东总数为24786人","url":"https://stock-news.laohu8.com/highlight/detail?id=2540758031","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540758031?lang=zh_cn&edition=full","pubTime":"2025-06-04 15:05","pubTimestamp":1749020726,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问，贵公司截止5月31日股东人数是多少？谢谢！汉森制药回复：投资者您好，截至2025年5月30日，公司含信用账户合并股东名册的股东总数为：24786人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400017079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002412","BK0039"],"gpt_icon":0},{"id":"2537160741","title":"每周股票复盘：汉森制药（002412）股东户数增加294户，户均持股减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2537160741","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537160741?lang=zh_cn&edition=full","pubTime":"2025-05-24 16:31","pubTimestamp":1748075469,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，汉森制药报收于5.71元，较上周的5.76元下跌0.87%。本周，汉森制药5月21日盘中最高价报5.92元。本周关注点股本股东变化：截至2025年4月30日公司股东户数为2.54万户，较3月31日增加294.0户公司公告汇总：2024年度股东大会于2025年5月21日召开，会议采取现场表决和网络投票相结合的方式股本股东变化近日汉森制药披露，截至2025年4月30日公司股东户数为2.54万户，较3月31日增加294.0户，增幅为1.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400013020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","002412","BK0239"],"gpt_icon":0},{"id":"2537189742","title":"汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537189742","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537189742?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:14","pubTimestamp":1747991688,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2025年4月30日公司股东户数为2.54万户，较3月31日增加294.0户，增幅为1.17%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至4月30日，中药行业平均股东户数为5.26万户。从股价来看，2025年3月31日至2025年4月30日，汉森制药区间跌幅为9.02%，在此期间股东户数增加294.0户，增幅为1.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300026398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002412","BK0039","BK0028"],"gpt_icon":0},{"id":"2535553383","title":"汉森制药：公司经营状况正常，无应披露未披露重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2535553383","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535553383?lang=zh_cn&edition=full","pubTime":"2025-05-16 08:48","pubTimestamp":1747356509,"startTime":"0","endTime":"0","summary":"金融界5月16日消息，有投资者在互动平台向汉森制药提问：公司年年利润看起来增长，但是股价低迷了快10年，难道有潜在的利空？可以请贵公司解释一下吗？公司回答表示：尊敬的投资者，您好！公司目前经营状况正常，且公司严格按照信息披露的要求及时、准确、完整披露相关信息，未有应披露而未披露的重大事项。感谢您对公司的关注。\n\n\r\n 责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16084850432446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002412","BK0028","BK0039"],"gpt_icon":0},{"id":"2535884633","title":"汉森制药：公司目前经营状况正常且未有应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2535884633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535884633?lang=zh_cn&edition=full","pubTime":"2025-05-16 08:48","pubTimestamp":1747356502,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)05月15日在投资者关系平台上答复投资者关心的问题。投资者提问：公司年年利润看起来增长，但是股价低迷了快10年，难道有潜在的利空？可以请贵公司解释一下吗汉森制药回复：尊敬的投资者，您好！公司目前经营状况正常，且公司严格按照信息披露的要求及时、准确、完整披露相关信息，未有应披露而未披露的重大事项。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600005882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0239","BK0028"],"gpt_icon":0},{"id":"2535501280","title":"汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535501280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535501280?lang=zh_cn&edition=full","pubTime":"2025-05-14 17:15","pubTimestamp":1747214159,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2025年4月30日公司股东户数为2.54万户，较3月31日增加294.0户，增幅为1.17%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至4月30日，中药行业平均股东户数为5.23万户。从股价来看，2025年3月31日至2025年4月30日，汉森制药区间跌幅为9.02%，在此期间股东户数增加294.0户，增幅为1.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400027560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002412","BK0039"],"gpt_icon":0},{"id":"2535027030","title":"汉森制药：截至2025年4月30日公司含信用账户合并股东名册的股东总数为25406人","url":"https://stock-news.laohu8.com/highlight/detail?id=2535027030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535027030?lang=zh_cn&edition=full","pubTime":"2025-05-14 08:42","pubTimestamp":1747183343,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问，贵公司截止5月10日股东人数是多少？谢谢！汉森制药回复：投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2025年4月30日，公司含信用账户合并股东名册的股东总数为：25406人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400006679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","002412","BK0239"],"gpt_icon":0},{"id":"2533977042","title":"汉森制药(002412)4月30日股东户数2.54万户，较上期增加1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533977042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533977042?lang=zh_cn&edition=full","pubTime":"2025-05-08 17:36","pubTimestamp":1746697006,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2025年4月30日公司股东户数为2.54万户，较3月31日增加294.0户，增幅为1.17%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至4月30日，中药行业平均股东户数为5.22万户。从股价来看，2025年3月31日至2025年4月30日，汉森制药区间跌幅为9.02%，在此期间股东户数增加294.0户，增幅为1.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050800024940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","002412","BK0028","BK0239"],"gpt_icon":0},{"id":"2531746158","title":"汉森制药：公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》","url":"https://stock-news.laohu8.com/highlight/detail?id=2531746158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531746158?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:51","pubTimestamp":1745974281,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：年报盈利了为啥不分红 赚的钱分出去又赚回来不就促进经济流通了吗 再说国家都提倡多分红以提高投资者获得感呢 公司多年股价持续下跌多年分红都不行 是这样回报投资者的吗汉森制药回复：尊敬的投资者您好，公司2024年根据新国九条及相关法律法规修订并披露《未来三年（2024-2026年）股东回报规划》，我们将严格执行现金分红规定和承诺，继续努力，为股东创造更多价值。感谢您的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000012137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0239","002412"],"gpt_icon":0},{"id":"2530496048","title":"异动快报：汉森制药（002412）4月28日9点38分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530496048?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:40","pubTimestamp":1745804453,"startTime":"0","endTime":"0","summary":"证券之星4月28日盘中消息，9点38分汉森制药（002412）触及跌停板。目前价格5.57，下跌9.87%。其所属行业中药目前下跌。领涨股为步长制药。该股为医药，优化生育（三孩），中药概念热股。4月25日的资金流向数据方面，主力资金净流入21.29万元，占总成交额0.38%，游资资金净流入253.81万元，占总成交额4.56%，散户资金净流出275.11万元，占总成交额4.95%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042800006717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0239","BK0028","BK0039"],"gpt_icon":0},{"id":"2530786172","title":"汉森制药（002412）2025年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2530786172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530786172?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:31","pubTimestamp":1745706687,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期汉森制药发布2025年一季报。根据财报显示，汉森制药增收不增利。截至本报告期末，公司营业总收入2.69亿元，同比上升6.0%，归母净利润1125.72万元，同比下降80.68%。本次财报公布的各项数据指标表现一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700001600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002412","BK0039","BK0028"],"gpt_icon":0},{"id":"2530165460","title":"图解汉森制药一季报：第一季度单季净利润同比减80.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530165460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530165460?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:08","pubTimestamp":1745604498,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药2025年一季报显示，公司主营收入2.69亿元，同比上升6.0%；归母净利润1125.72万元，同比下降80.68%；扣非净利润911.64万元，同比下降83.48%；负债率13.86%，投资收益-4527.96万元，财务费用25.13万元，毛利率76.59%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"gpt_icon":0},{"id":"2530027132","title":"汉森制药(002412.SZ)发布一季度业绩，归母净利润1125.72万元，同比下降80.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530027132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530027132?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:18","pubTimestamp":1745590708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汉森制药(002412.SZ)发布2025年一季度报告，第一季度，公司实现营业收入2.69亿元，同比增长6.00%。归属于上市公司股东的净利润1125.72万元，同比下降80.68%。归属于上市公司股东的扣除非经常性损益的净利润911.64万元，同比下降83.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002412"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753483441068,"stockEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0942},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1463},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.1215}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南汉森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24786人(较上一季度减少2.44%)","perCapita":"20085股","listingDate":"2010-05-25","address":"湖南省益阳市赫山区银城大道2688号","registeredCapital":"50320万元","survey":" 湖南汉森制药股份有限公司的主营业务是传统中成药制剂、化学药、医用制剂的研发、生产和销售。公司的主要产品是中成药、化学药、医用制剂。","listedPrice":35.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉森制药,002412,汉森制药股票,汉森制药股票老虎,汉森制药股票老虎国际,汉森制药行情,汉森制药股票行情,汉森制药股价,汉森制药股市,汉森制药股票价格,汉森制药股票交易,汉森制药股票购买,汉森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}